US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genfit

3.54

0.0000

Volume:- -

Turnover:- -

Market Cap:176.15M

PE:-5.51

High:3.54

Open:3.54

Low:3.54

Close:3.54

Loading ...

Overview Company News Filings

GENFIT Finalizes 2025 Bond Repurchase Terms Amidst Royalty Financing Deal

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders

Kepler Capital Reaffirms Their Buy Rating on Genfit (GNFTF)

Genfit Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Genfit SA’s Promising Clinical Milestones and Financial Stability Underpin Buy Rating

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025

Kepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan

GENFIT Announces 2025 Financial Calendar

GENFIT Releases Half-Year Liquidity Contract Report

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GNFTF/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNFTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNFTF\",,,,,undefined,":{"symbol":"GNFTF","market":"US","secType":"STK","nameCN":"Genfit","latestPrice":3.54,"timestamp":1749844800000,"preClose":3.54,"halted":0,"volume":0,"delay":15,"floatShares":41846888,"shares":49758671,"eps":-0.642605,"marketStatus":"Market Closed","change":0,"latestTime":"06-13 16:00:00 EDT Delay","open":3.54,"high":3.54,"low":3.54,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.642605,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.54,"volumeRatio":0.08714597519472606},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNFTF\",,,,,undefined,":{"symbol":"GNFTF","floatShares":41846888,"roa":"1.14%","roe":"2.20%","lyrEps":-0.642605,"volumeRatio":0.08714597519472606,"shares":49758671,"dividePrice":0,"high":3.54,"amplitude":0,"preClose":3.54,"low":3.54,"week52Low":3.44,"pbRate":"2.20","psRate":"2.16","week52High":5.55,"institutionHeld":0,"latestPrice":3.54,"eps":-0.642605,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.642605,"open":3.54,"prevYearClose":3.54,"prevWeekClose":3.54,"prevMonthClose":3.54,"prevQuarterClose":3.54,"fiveDayClose":3.54,"twentyDayClose":3.54,"sixtyDayClose":3.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNFTF\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510465858","title":"GENFIT Finalizes 2025 Bond Repurchase Terms Amidst Royalty Financing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2510465858","media":"TIPRANKS","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510465858?lang=en_us&edition=fundamental","pubTime":"2025-02-10 19:28","pubTimestamp":1739186902,"startTime":"0","endTime":"0","summary":"Genfit SA ( ($GNFT) ) has issued an announcement. On February 10, 2025, GENFIT announced the final terms for a dual proposal to its 2025 OCEANEs bo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-finalizes-2025-bond-repurchase-terms-amidst-royalty-financing-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-finalizes-2025-bond-repurchase-terms-amidst-royalty-financing-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","US12M.BOND","BK4139","US3Y.BOND","US6M.BOND","US30Y.BOND","US7Y.BOND","US2Y.BOND","US10Y.BOND","US5Y.BOND"],"gpt_icon":0},{"id":"2510886345","title":"GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886345","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510886345?lang=en_us&edition=fundamental","pubTime":"2025-02-10 14:30","pubTimestamp":1739169000,"startTime":"0","endTime":"0","summary":"In conjunction with the royalty financing deal with HealthCare Royalty  announced on January 30, 2025, GENFIT will request the consent of the holders of 2025 OCEANEs and proposes:. to repurchase the 2025 OCEANEs at EUR 32.00 per bond from interested bondholders, or alternatively. to pay a consent fee of EUR 0.60 per bond still outstanding after the upcoming bondholder meeting and cancellation of the repurchased 2025 OCEANEs. Both proposals are subject to approval of the royalty financing by the 2025 OCEANEs bondholders at the upcoming bondholders meeting and closing of the royalty financing. Lille , Cambridge , Zurich , February 10, 2025 - GENFIT , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the final terms of the 2025 OCEANEs repurchase proposal and the consent fee that would be paid to the holders of 2025 OCEANEs still outstanding after cancellation of repurchased 2025 OCEANEs.Concurrently wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-announces-final-terms-dual-063000451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USA","CCA","GNFT","PBC","GNFTF","BK4139"],"gpt_icon":0},{"id":"2510509568","title":"Kepler Capital  Reaffirms Their Buy Rating on Genfit (GNFTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510509568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510509568?lang=en_us&edition=fundamental","pubTime":"2025-02-09 09:46","pubTimestamp":1739065599,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Justine Telliez maintained a Buy rating on Genfit (GNFTF – Research Report) on February 7 and set a price target of €8.40. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-genfit-gnftf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-genfit-gnftf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF"],"gpt_icon":0},{"id":"2509481037","title":"Genfit Price Target Maintained With a $13.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2509481037","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509481037?lang=en_us&edition=fundamental","pubTime":"2025-02-07 20:45","pubTimestamp":1738932300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GNFT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 07, 2025 07:45 ET (12:45 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNFT","GNFTF"],"gpt_icon":0},{"id":"2509371431","title":"Genfit SA’s Promising Clinical Milestones and Financial Stability Underpin Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2509371431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509371431?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:37","pubTimestamp":1738928253,"startTime":"0","endTime":"0","summary":"Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Genfit SA (GNFT – Research Report), with a price target of $13.00. Ed Arce’s rating i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/genfit-sas-promising-clinical-milestones-and-financial-stability-underpin-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/genfit-sas-promising-clinical-milestones-and-financial-stability-underpin-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF"],"gpt_icon":0},{"id":"2509784847","title":"GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509784847","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509784847?lang=en_us&edition=fundamental","pubTime":"2025-02-07 05:10","pubTimestamp":1738876200,"startTime":"0","endTime":"0","summary":"2 new ACLF clinical trials expected to initiate in 1Q25. 3 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT Phase 2 trial. Data of on-going Phase 1b also expected by year-end 2025 for GNS561/trametinib in KRAS-mutated cholangiocarcinoma, to support dose selection for Phase 2. Lille , Cambridge , Zurich , February 6, 2025-GENFIT ,a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today outlines the design of new clinical trials within its Acute on-Chronic Liver Failure  pipeline, with several clinical data readouts by end of 2025.This integrated approach ensures a comprehensive foundation to advance our ACLF pipeline. Notably, it has provided the rationale for including a subset of patients with AD at a high-risk of progressing to ACLF in our target population for the new trials. Broadening inclusion criteria to cover the ACLF continuum creates opportunities to add","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-outlines-anticipated-clinical-trial-211000282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4081","CCA","GNFT","BK4139","PBC","USA","GNFTF","HE"],"gpt_icon":0},{"id":"2508391291","title":"Kepler Capital  Sticks to Its Buy Rating for Genfit (GNFTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508391291","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508391291?lang=en_us&edition=fundamental","pubTime":"2025-02-01 09:36","pubTimestamp":1738373819,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Justine Telliez maintained a Buy rating on Genfit (GNFTF – Research Report) on January 30 and set a price target of €8.40. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-genfit-gnftf-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-genfit-gnftf-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF"],"gpt_icon":0},{"id":"2507614578","title":"GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2507614578","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507614578?lang=en_us&edition=fundamental","pubTime":"2025-01-30 15:40","pubTimestamp":1738222800,"startTime":"0","endTime":"0","summary":"GENFIT signs royalty financing deal with HealthCare Royalty  providing up to 185 million non-dilutive capital:. 130 million upfront, with eligibility to receive up to 55 million in two additional instalments based on near-term milestones. Closing subject to approval by the 2025 OCEANE bondholders at upcoming bondholders meeting. Financing would extend cash runway beyond the end of 2027, assuming drawdown of all instalments. Proceeds to further strengthen the development of the ACLF pipeline. In return, HCRx will receive a portion of royalties on global1 sales of Iqirvo  payable to GENFIT under its licensing agreement with Ipsen, up to an agreed upon cap after which all future royalties will revert back to GENFIT. GENFIT retains rights to all future regulatory, commercial and sales-based milestone payments from Ipsen under the Ipsen agreement. GENFIT to concurrently propose a repurchase of the 2025 OCEANEs aiming to completely eliminate GENFIT’s convertible debt overhang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-announces-non-dilutive-royalty-074000804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","CCA","GNFT","USA","BK4139","GNFTF"],"gpt_icon":0},{"id":"2507665944","title":"GENFIT Announces 2025 Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2507665944","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507665944?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:10","pubTimestamp":1738185000,"startTime":"0","endTime":"0","summary":"Lille , Cambridge , Zurich , January 29, 2025 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2025.Publication of revenue and cash position at December 31, 2024. Publication of Full Year 2024 financial statements  The 2024 Universal Registration Document and Annual Financial Report , as well as the Annual Report on Form 20-F will be made public by the end of April 2025.This press release contains certain forward-looking statements, including those w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-announces-2025-financial-calendar-211000875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","GNFT","USA","CCA","GNFTF","BK4139"],"gpt_icon":0},{"id":"2503075555","title":"GENFIT Releases Half-Year Liquidity Contract Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2503075555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503075555?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:34","pubTimestamp":1736804070,"startTime":"0","endTime":"0","summary":"An update from Genfit SA ( ($GNFT) ) is now available. GENFIT announced the half-year report of its liquidity contract with Crédit Industriel et Co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-releases-half-year-liquidity-contract-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-releases-half-year-liquidity-contract-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNFTF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-11-10","symbol":"GNFTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668056400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-09-28","symbol":"GNFTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1664337600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-04-07","symbol":"GNFTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1649304000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNFTF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNFTF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1662868800000}}}